Andreone, Pietro

Publishing since 1987 (Dinosaur)

Has published 86 publications in 24 years

Number of publications published per year by Andreone, Pietro. (Source : PubMed)

Distribution of publications types for Andreone, Pietro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G, Ferrari C. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.  Gastroenterology  2010;138;2  
•  Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.  J. Clin. Gastroenterol.  2010;44;1  
•  Gramenzi A, Cursaro C, Margotti M, Balsano C, Spaziani A, Anticoli S, Loggi E, Salerno M, Galli S, Furlini G, Bernardi M, Andreone P. Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.  World J. Gastroenterol.  2009;15;47  
•  Gitto S, Lorenzini S, Biselli M, Conti F, Andreone P, Bernardi M. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.  Dig Liver Dis  2009;41;10  
•  Gramenzi A, Conti F, Felline F, Cursaro C, Riili A, Salerno M, Gitto S, Micco L, Scuteri A, Andreone P, Bernardi M. Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.  J. Viral Hepat.  2009  
•  Jensen DM, Marcellin P, Freilich B, Andreone P, Di Bisceglie A, Brandão-Mello CE, Reddy KR, Craxi A, Martin AO, Teuber G, Messinger D, Thommes JA, Tietz A. Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial.  Ann. Intern. Med.  2009;150;8  
•  Biselli M, Vitale G, Gramenzi A, Riili A, Berardi S, Cammà C, Scuteri A, Morelli MC, Grazi GL, Pinna AD, Andreone P, Bernardi M. Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant.  Clin Transplant  2009;23;2  
•  Loggi E, Bihl F, Chisholm JV, Biselli M, Bontadini A, Vitale G, Ercolani G, Grazi GL, Pinna AD, Bernardi M, Brander C, Andreone P. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft.  J. Hepatol.  2009;50;3  
•  Corradi F, Piscaglia F, Flori S, D'Errico-Grigioni A, Vasuri F, Tamé MR, Andreone P, Boni P, Gianstefani A, Bolondi L. Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography.  Dig Liver Dis  2009;41;3  
•  Andriulli A, Cursaro C, Cozzolongo R, Iacobellis A, Valvano MR, Mangia A, Minerva N, Bacca D, Stanzione M, Scuteri A, Montalto G, Andreone P. Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.  J. Viral Hepat.  2009;16;1  

[ See timeline ] [ See all publications ]